Xenpozyme (olipudase alfa,GZ402665)
PTA17397
Phase 2 small_molecule active
Quick answer
Xenpozyme (olipudase alfa,GZ402665) for Niemann-Pick disease is a Phase 2 program (small_molecule) at Sanofi Winthrop Industrie with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Winthrop Industrie
- Indication
- Niemann-Pick disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active